Friday, 30th August The Annual Scientific Meeting of the Australian Diabetes Society and the Australian Diabetes Educators Association 2013

Modern Approaches to Effective Glycaemic Control

The combination of metformin plus a sulfonyurea is broadly used for the treatment of type 2 diabetes. However, many patients on dual therapy still do not achieve glycaemic control. Adding a third oral agent can be an option for patients before initiating insulin therapy. The symposium will focus on the role of vildagliptin in this setting.

Managing obesity in Type 2 Diabetes – what are the options?

Obesity is a complex condition to manage, and is even more challenging for patients with diabetes, particularly those on medications including insulin. This presentation will provide an overview of the treatment options available and the relative merits of each. It will also provide some insights into the practicalities of managing diabetes medications while patients are on restricted eating plans.

• Successful, cost effective interventions for improvement of lifestyle, prevention of weight gain and ultimately reduction of diabetes risk: a successful exemplar - Helena Teede
• Type 1 diabetes trials highlights   - Peter Colman
• Management of Type 2 Diabetes - Christopher Nolan
• Lipid lowering strategies in diabetes - Tony Keech

GP CME Eligible Session

• Apps for the management of diabetes - Ian Gillespie
• The practicalities of Telehealth: doing it right doing it well - David Allen
• Not enough time in the day? Must have tips, tricks and technologies to save you time - Natalie Wischer

• Activation of the cAMP-dependent protein kinase (PKA) in β-cells provides sustained benefits to glucose control - Barton Wicksteed
• Loss of beta cell heparan sulfate (HS) during islet isolation increases susceptibility to oxidant-mediated damage - Charmaine Simeonovic
• Partial deletion of the selenoprotein SEPS1 in β-cells leads to impairment in insulin secretion - Steve Weng
• Regulation of β-catenin mediates the effect of glucose and increntin on insulin secretion in pancreatic β-cells    - Brie Sorrenson
• Identification of Cytokines that Cause or Repress ER Stress in β-cells – Therapeutic Manipulation Reverses Hyperglycaemia in Type 2 Diabetes - Michael McGuckin
• Proinsulin-specific CD4⁺ T cells infiltrate human islets in type 1 diabetes - Stuart I Mannering

• High fat diet induced cardiac insulin resistance occurs independently of myocardial lipotoxicity and without impairments in the insulin signaling cascade. - Darren C Henstridge
• Multigeneration Undernutrition, Central adiposity and nutrient transition - a Thrifty Jerry - Anandwardhan Hardikar
• HDL MODULATES GLUCOSE METABOLISM IN CARDIOMYOCYTES - Sarah E Heywood
• Maternal high fat diet, in absence of obesity, causes insulin resistance and alters skeletal muscle oxidative phosphorylation in adult rat offspring - Celine Latouche
•  Identifying Type 2 Diabetes Susceptibility Loci Using The "Gene Mine" - Salvatore P Mangiafico
• Fructose Diet-Induced ER Stress Involves Suppressed Autophagy via the mTOR Signalling Pathway - Hao Wang

GP CME Eligible Session

• Developmental Programming of Type 2 Diabetes – Physiological Mechanisms and Role of Genetic versus Epigenetic Factors - Allan Vaag
• Breastfeeding in the Prevention of Cardiometabolic Diseases in Women with GDM and their Offspring - Erica Gunderson

The ADEA Standards for Initiating Insulin Therapy in Ambulatory Care Settings (2013) provide health professionals with a process for addressing outcomes, processes and structure around insulin initiation. 

 The symposium will look at both QUM in the context of the use of insulin and discuss the role and scope of practice of the CDE now and in the future

• Quality use of Medicines; Role of the Credentialed Diabetes Educator in the Ambulatory Care Setting - Kirsty Lembke